Biopharma Credit Plc announces new investment
LONDON: BioPharma Credit along with its subsidiary BioPharma-V has entered into a US$300 million definitive senior secured loan agreement with LumiraDx Investment Limited and LumiraDx Group Limited. The Company will invest US$150 million and BioPharma-V will invest an additional US$150 million. Based in the UK, LumiraDx is a next-generation point of care, or POC, diagnostic…